The largest database of trusted experimental protocols

13 protocols using tetracycline

1

Scalable RNAi Library Preparation

Check if the same lab product or an alternative is used in the 5 most similar protocols
OrthoList RNAi plates were replicated in LB agar, and bacteria were grown overnight at 37 °C. The advantage of growing the bacteria in solid media is the ease of visualising the clones where the bacteria did not grow. If needed, the samples can be kept at 4 °C for 2 days maximum. Next day, we inoculated the RNAi library in 2.2-ml 96-well plates (VWR). Using the pin replicator, we inoculated the bacteria from the LB agar into 1.2 ml of LB supplemented with ampicillin (100 μg/ml, Sigma-Aldrich) and tetracycline (15 μg/ml, Sigma-Aldrich). Positive and negative controls were added in the last column of the plate. We cultured the bacteria overnight at 37 °C with shaking (180 rpm, New Brunswick™ Innova® 44/44R). In order to have fresh cultures, on the day of sorting, we inoculated 100 μl of the O/N cultures in 900 μl of LB supplemented with ampicillin and tetracycline in deep well plates (VWR) and incubated for 3 h at 37 °C with shaking. We added isopropylthio-β-galactoside (IPTG, 1 mM, Sigma-Aldrich) to the wells to induce the expression of the plasmid for 2 h at 37 °C with shaking. Then, we harvested the cultures by centrifugation (10 min, 3200 g, 4 °C, Eppendorf 5810R) and re-suspended the pellets in 250 μl of S-medium supplemented with carbenicillin (25 μg/ml, Sigma-Aldrich), IPTG (1 mM, Sigma-Aldrich) and cholesterol (5 μg/ml, Sigma-Aldrich).
+ Open protocol
+ Expand
2

Antimicrobial Resistance Phenotypes

Check if the same lab product or an alternative is used in the 5 most similar protocols
We performed phenotypic antimicrobial susceptibility testing to investigate the occurrence of additional clinically relevant resistance phenotypes. Briefly, a single colony was picked and streaked on chromogenic agar plates containing antibiotics at their clinical breakpoint concentrations according to the published breakpoints of the Clinical and Laboratory Standards Institute [72 ]. We used the antibiotics tetracycline (16 μg/mL; VWR International, Radnor, PA, USA), gentamicin (2 μg/mL; Carl Roth, Karlsruhe, Germany), and ciprofloxacin (1 μg/mL; VWR International, Radnor, PA, USA). The minimum inhibitory concentration of colistin was determined using the MICRONAUT MIC-Strip Colistin Assay (Merlin Diagnostika, Bornheim, Germany) according to the manufacturer’s instructions.
+ Open protocol
+ Expand
3

Genetic Manipulation of Salmonella and E. coli

Check if the same lab product or an alternative is used in the 5 most similar protocols
The derivatives of Salmonella enterica serovar Typhimurium strain 14028s and Escherichia coli, as well as the plasmids used in this study, are listed in Tables S2 and S3. Deletion mutants were constructed using the λ-Red homologous recombination system45 (link). Pfu ultra high-fidelity DNA polymerase (cat. # 600382-51, Agilent, Santa Clara, CA) was used to perform genetic mutagenesis using primers described in Table S4. Bacteria were grown in LB broth at 37 °C in a shaker incubator. Penicillin (cat. # J63032, AlfaAesar), chloramphenicol (cat. # 0230, Amresco), tetracycline (cat. # 0422, Amresco), and kanamycin (cat. # K-120, Goldbio) were added at the final concentrations of 250, 40, 20, or 50 μg/ml, respectively.
+ Open protocol
+ Expand
4

Antibiotic Susceptibility Profiling of E. coli

Check if the same lab product or an alternative is used in the 5 most similar protocols
Antibiotic susceptibility profiles of all the clinical isolates were tested against a panel of eighteen different antibiotics using the Kirby-Bauer disk diffusion method on Muller-Hinton agar (Difco™) as per standard guidelines of CLSI [32 ]. The antimicrobial agents included ampicillin, amoxicillin/clavulanic acid, cephalexin, cefaclor, cefoxatin, cefotaxime, ceftazidime, cefepime, aztreonam, meropenem, nalidixic acid, chloramphenicol, ciprofloxacin, trimethoprim/sulphamethoxazole, tetracycline, gentamicin, cefotaxime/ clavulanic acid and ceftazidime/clavulanic acid (BD BBL™, Oxoid™). Minimum inhibitory concentrations by broth microdilution method of the selected common antibiotics (ampicillin, cefazolin, cefoxatin, cefotaxime, ceftriaxone, ciprofloxacin, norfloxacin, trimethoprim (BBI Life Sciences Corporation, Shanghai, China), amikacin, chloramphenicol, gentamicin, kanamycin and tetracycline (Amresco, OH, USA)) for the ESBL-producing E. coli were also determined in accordance with the guidelines of the CLSI [32 ]. ESBL negative quality control strain was E. coli ATCC25922, whereas, Klebsiella pneumoniae ATCC700603 was used as ESBL positive control strain [32 ]. Multidrug resistant isolates were those found resistant to at least three or more categories of antimicrobial agents.
+ Open protocol
+ Expand
5

Cultivation and Transformation of Mycoplasma bovis and Escherichia coli

Check if the same lab product or an alternative is used in the 5 most similar protocols

M. bovis type strain PG45 (ATCC 25523) was cultured at 37°C in modified Frey's broth (21 g PPLO, 37 ml yeast extract, 100 ml inactivated swine serum, 4 ml 1.6% phenol red solution, 300 mg penicillin G, 859 ml distilled water, pH adjusted to 7.8) or on mycoplasma agar plates (modified Frey's broth without phenol red with 1% agar added). For the selection of M. bovis transformants, gentamicin (Invitrogen) or tetracycline (Sigma Aldrich) was added to media to a concentration of 50 µg/ml or 5 µg/ml, respectively.
Escherichia coli DH5α cells (Life Technologies) were used for cloning of different transposon constructs and were cultured at 37°C in Luria-Bertani (LB) broth (1% w/v tryptone (Oxoid), 0.5% w/v yeast extract (Oxoid), 0.5% w/v NaCl) with shaking at 200 rpm on an orbital shaker incubator (Ratek) or on LB agar plates (LB broth containing 1% bacteriological agar). Selection of plasmid-transformed E. coli DH5α cells was performed on LB agar containing 5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside (X-gal) (Sigma) at 40 µg/ml, isopropyl-β-D-thiogalactopyranoside (IPTG) (Sigma) at 50 µg/ml and an appropriate antibiotic. E. coli DH5α containing plasmid constructs were grown in LB broth or on LB agar plates containing ampicillin (Amresco) at 100 µg/ml, gentamicin at 20 µg/ml or tetracycline at 4 µg/ml.
+ Open protocol
+ Expand
6

Lipid Metabolism Regulation Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Fenofibrate (Feno) from Fournier Pharma (France); Fluvastatin (Flu) from Beijing Novartis Pharma Ltd; Tetracycline was purchased from AMRESCO (USA); Polyene Phosphatidylcholine (PPC) from Sanofi, Beijing (China); Rosiglitazone (Rosi) from GSK, China; Anti-β-actin antibody, anti-FAS antibody, anti-ACC antibody from Cell Signaling Technology (USA); anti-MTTP antibody, anti-CPT-1 antibody, anti-CD36 antibody from Abcam (USA); anti-SREBP-1c antibody from SANTA (USA); commercial kits for liver triglyceride, ECL reactions from Applygen Technologies Inc.
+ Open protocol
+ Expand
7

Cultivation and Maintenance of E. piscicida and E. coli

Check if the same lab product or an alternative is used in the 5 most similar protocols
Bacterial strains and plasmids used in this study are described in Table 2. E. piscicida PPD130/91 (43 (link)) and its derived strains were grown in tryptic soy broth (TSB; BD Biosciences) at 28°C, and Escherichia coli strains were cultured in Luria-Bertani broth (LB; BD Biosciences). E. piscicida strains were grown in DMEM (Thermo Fisher) at 25°C under a 5% (vol/vol) CO2 atmosphere to switch on its T3SS. When required, appropriate antibiotics were supplemented at the following concentrations: 100 µg/mL ampicillin (Sigma), 50 µg/mL kanamycin (Sigma), 12.5 µg/mL colistin (Sigma), 15 µg/mL tetracycline (Amresco), and 34 µg/mL chloramphenicol (Amresco).
Murine J774A.1 macrophages were cultured at 35°C in DMEM (Gibco) with 10% fetal bovine serum (FBS). Epithelioma papillosum cyprini (EPC) cells (52 (link)) were grown at 25°C in MEM medium (HyClone) supplemented with 10% FBS.
+ Open protocol
+ Expand
8

Eliminating Wolbachia from Culex Mosquitoes

Check if the same lab product or an alternative is used in the 5 most similar protocols
Tetracycline treatment to eliminate Wolbachia from Culex populations was carried out according to published methods [28 (link)]. Tetracycline (Amresco) at a concentration of 0.05 mg/ml was used for the treatment through both larval and pupal stages. Eggs were placed on Tetracycline water solution to hatch. Surviving larvae were transferred to fresh Tetracycline solution every 24 hours. A normal infusion was prepared in parallel and fed to larvae in Tetracycline solution. After continuous Tetracycline treatment for 6 generations, Wolbachia-negative Culex populations were established.
+ Open protocol
+ Expand
9

Antibiotic Susceptibility Profiling of Acinetobacter baumannii

Check if the same lab product or an alternative is used in the 5 most similar protocols
The strains used in this study are listed in Table 5. Escherichia coli DH5α was used as the cloning host for plasmid construction. Luria-Bertani (LB) medium was used to propagate A. baumannii and E. coli. The LB plates contained 1.5 g/liter agar. Kanamycin and tetracycline were purchased from Amresco, and colistin E was purchased from Apeloa. Colistin E MICs were measured by the broth microdilution method according to the Clinical and Laboratory Standards Institute (CLSI) guidelines (32 ).
+ Open protocol
+ Expand
10

Bacterial Strain Preparation and Culture

Check if the same lab product or an alternative is used in the 5 most similar protocols
All strains used in this study are listed in Supplementary Table 3.
Selective media for cloning purposes were prepared with LB broth or LB-agar using antibiotics at the following final concentrations: 10 μg/ml chloramphenicol (Amersco), 10 µg/ml, 10 μg/ml spectinomycin (Tivan biotech), 10 µg/ml tetracycline (Amresco), 1 µg/ml erythromycin (Amresco) + 25 µg/ml lincomycin (Sigma). Starter cultures of all strains was prepared using LB (Luria- Bertani) broth (Difco). B4 (0.4% yeast extract, (Difco), 0.5% D-glucose and 0.25% calcium acetate (Sigma Aldrich)) was prepared as described previously55 (link).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!